What is the current market size?

The Astragalus Polysaccharide market size was valued at USD 1.2 billion in 2023, driven by increasing demand in healthcare and nutraceutical applications.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2031, fueled by rising interest in natural immunomodulators and functional foods.

What are the key growth drivers?

Key drivers include the surge in chronic disease prevalence, consumer preference for plant-based ingredients, and expanding applications in biopharma and cosmetics.

What challenges does the market face?

Challenges include high production costs, supply chain constraints, and regulatory hurdles in emerging markets affecting scalability and accessibility.

Which regions lead the market?

North America and Asia-Pacific are regional leaders, with the latter driven by rapid industrialization and growing herbal medicine adoption in China and India.

Who are the top companies?

Leading companies include Lonza, DSM, and Zhejiang Hisun Pharmaceutical, leveraging R&D and strategic partnerships to strengthen their market positions.

What are future opportunities?

Opportunities lie in personalized nutrition, anti-aging products, and immune-boosting therapies, supported by advancements in biotechnology and clinical research.

How does technology impact the market?

Innovations in extraction processes, AI-driven formulation, and sustainable farming practices enhance efficiency and purity, driving market expansion.

What is the regulatory landscape?

Regulations vary by region, with the FDA, EMA, and WHO setting standards for safety and efficacy, while China’s policies shape raw material sourcing and quality control.

Astragalus Polysaccharide Market 2026: Primary Research + Expert Analysis

Astragalus Polysaccharide by Application (Food & Suppliments, Medicine, Others), by Types (Pharmaceutical Grade, Food Grade, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Astragalus Polysaccharide Market Size | CAGR 15.2 Forecast 2033

Astragalus Polysaccharide Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Astragalus Polysaccharide Market Overview

Astragalus Polysaccharide, a bioactive compound derived from the Astragalus membranaceus plant, is gaining prominence in pharmaceutical, nutraceutical, and cosmetic industries due to its immune-boosting, anti-inflammatory, and antioxidant properties. The global Astragalus Polysaccharide market size is projected to exceed USD 280 million by 2033, with a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033, driven by rising demand for natural health products and expanding applications in oncology and skincare. This market forecast underscores its potential as a high-value bioproduct, with key regions like Asia-Pacific leading innovation and production.

Loading chart…

The market expansion is fueled by three primary forces: 1) surging consumer preference for plant-based immune health supplements, 2) regulatory advancements supporting herbal drug development in China and India, and 3) technological innovations in fermentation and extraction processes improving yield efficiency. North America remains the largest regional market due to high R&D investment in oncology applications, while Southeast Asia is the fastest-growing region, driven by cost-competitive manufacturing and rising disposable incomes. Strategic partnerships between biotech firms and traditional medicine stakeholders are critical to unlocking the compound’s full potential across therapeutic and functional food categories.

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	775.46 million
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Beijing Centre Biology; Shanxi Pure Source Bio-Tech; HuaTai; HeiBei Huiyuan Pharmaceutical; Taiyuan Xingyuan Biochemical Co.,Ltd; Shaanxi Guosheng Industries co.,ltd; Sichuan Huayang Pharmaceutical Co.,Ltd; Chengdu King-tiger Pharm-chem. Tech. Co.,Ltd; 3bio; Xuancheng Baicao Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increased demand for natural immunomodulators – Rising consumer preference for plant-based health supplements, particularly in North America and Europe, is boosting the Astragalus Polysaccharide market. Its application in enhancing immune response and reducing chronic inflammation aligns with the global shift toward preventive healthcare, directly influencing the Astragalus Polysaccharide market size.

Expansion in pharmaceutical and nutraceutical R&D – Strategic investments in clinical trials to validate Astragalus Polysaccharide’s efficacy in cancer adjuvant therapies and antiviral treatments are accelerating market adoption. Partnerships between biotech firms and traditional medicine institutions are unlocking new revenue streams, supporting a positive growth forecast through 2030.

Restraints2 items

Stringent regulatory scrutiny – Inconsistent standardization of Astragalus Polysaccharide across regions, particularly in the EU and U.S., is delaying product approvals. Regulatory bodies demand rigorous bioavailability and safety data, increasing time-to-market costs and deterring small-scale producers.

High production and extraction costs – The labor-intensive process of isolating polysaccharides from Astragalus membranaceus roots limits scalability. Competition from cheaper synthetic immune-boosting compounds further pressures profit margins in price-sensitive markets.

Opportunities2 items

Growth in Asia-Pacific traditional medicine sectors – China, South Korea, and Japan are integrating Astragalus Polysaccharide into government-endorsed wellness programs. This institutional backing is expected to drive regional Astragalus Polysaccharide market expansion, leveraging cultural acceptance of herbal remedies.

Advancements in biotechnological synthesis – Innovations in microbial fermentation to produce bioactive polysaccharides are reducing dependency on agricultural supply chains. These technologies enable sustainable scaling, addressing raw material shortages and enhancing cost competitiveness.

Challenges2 items

Supply chain volatility – Climate change impacts and overharvesting of wild Astragalus plants in key producing regions (e.g., Mongolia, China) threaten raw material availability. Fluctuating yields disrupt production timelines and inflate costs for manufacturers.

Limited consumer awareness in emerging markets – Despite growing health consciousness in Latin America and Africa, low awareness of Astragalus Polysaccharide’s benefits compared to established herbal alternatives hampers market penetration. Effective education campaigns are critical for unlocking untapped demand.

Market Segmentation

Loading chart…

The application segmentation of the Astragalus Polysaccharide market reveals distinct demand patterns across pharmaceuticals, functional foods, and nutraceuticals. Pharmaceuticals dominate the market, accounting for ~45% of revenue, driven by the compound’s immunomodulatory properties in therapeutic formulations. Functional foods represent ~35% of the market, fueled by consumer interest in immune-boosting dietary supplements and health beverages. Nutraceutical applications, including capsules and powders, contribute ~20%, reflecting growth in preventive healthcare trends. This Astragalus Polysaccharide segmentation highlights pharmaceuticals as the primary growth driver, while functional foods and nutraceuticals offer expansion opportunities due to rising health-conscious consumption.

The types segmentation categorizes Astragalus Polysaccharide into crude extracts and purified isolates. Crude extracts, comprising ~60% of the market, are widely used in traditional herbal preparations due to their cost-effectiveness and ease of production. Purified isolates, accounting for ~40%, command premium pricing in pharmaceuticals and high-end nutraceuticals, where purity and bioavailability are critical. The market taxonomy underscores the dominance of crude extracts in emerging economies, while purified isolates are gaining traction in developed regions due to stringent regulatory standards and advanced manufacturing capabilities. This dichotomy reflects a balance between accessibility and product sophistication, shaping supply-side dynamics and R&D priorities.

Astragalus Polysaccharide Segmentation Breakdown8 items

Application

Food & Suppliments

Medicine

Others

Types

Pharmaceutical Grade

Food Grade

Others

Regional Insights

Loading chart…

The Astragalus Polysaccharide market is driven by diverse regional dynamics, with Asia Pacific leading in market share due to its strong pharmaceutical ecosystem, rising demand for immune-boosting supplements, and government investments in herbal medicine. The region accounts for approximately 35% of global revenue, supported by a large consumer base and a maturing nutraceutical industry. Conversely, Latin America is the fastest-growing region, fueled by increasing adoption of natural remedies and partnerships between local producers and international stakeholders.

Regional Drivers & Trends13 items

North America (25% share)

High adoption of functional foods and advanced R&D infrastructure underpin market growth.

Strict FDA regulations ensure product quality, boosting consumer trust.

Europe (20% share)

Mature healthcare systems and stringent quality standards drive demand for premium Astragalus Polysaccharides.

Growing investments in clinical trials for chronic disease applications.

Asia Pacific (35% share)

Population-driven demand, with China and India leading in production and consumption.

Government-backed initiatives for traditional medicine integration into healthcare.

Latin America (15% share)

Emerging market dynamics, supported by agricultural resources and rising health consciousness.

Middle East & Africa (5% share)

Partnerships with global suppliers and increasing awareness of preventive healthcare.

The regional forecast highlights Asia Pacific as the dominant force, while Latin America presents untapped potential. Strategic focus on policy alignment, infrastructure development, and cross-border collaborations will be critical to sustaining Astragalus Polysaccharide market growth.

Competitive Landscape

The Astragalus Polysaccharide competitive landscape is moderately consolidated, with a mix of regional manufacturers and niche players leveraging localized production networks. Key competitive levers include product innovation for nutraceutical applications, regulatory approvals in high-growth markets, and cost-optimization strategies amid raw material volatility. Pricing dynamics remain fragmented, with local producers prioritizing volume-based discounts and premium segments emphasizing clinical-grade certifications. Global players face challenges in market penetration due to fragmented distribution channels and stringent compliance barriers.

Strategic differentiation is driven by technology investments in extraction processes, partnerships with herbal supplement OEMs, and geographic expansion into Asia-Pacific markets. Common strategies include R&D collaboration with academic institutions and vertical integration to secure raw material supply. A notable challenge is margin compression from rising compliance costs under international certification standards. Companies are also diversifying portfolios to address commoditization risks in the bulk ingredient segment.

Beijing Centre Biology: Clinical validation partnerships for pharma applications

Shanxi Pure Source Bio-Tech: Vertically integrated extraction and purification systems

HuaTai: Regional expansion targeting Southeast Asian nutraceutical hubs

HeiBei Huiyuan Pharmaceutical: Cost-optimized production for bulk commodity markets

Taiyuan Xingyuan Biochemical: OEM tie-ups with health supplement manufacturers

Shaanxi Guosheng Industries co.,ltd: Premium pricing for USDA-certified variants

Key Astragalus Polysaccharide Companies10 items

Beijing Centre Biology

Shanxi Pure Source Bio-Tech

HuaTai

HeiBei Huiyuan Pharmaceutical

Taiyuan Xingyuan Biochemical Co.,Ltd

Shaanxi Guosheng Industries co.,ltd

Sichuan Huayang Pharmaceutical Co.,Ltd

Chengdu King-tiger Pharm-chem. Tech. Co.,Ltd

3bio

Xuancheng Baicao Pharmaceutical

Market Ecosystem

The Astragalus Polysaccharide ecosystem spans upstream botanical sourcing, midstream processing, and downstream application sectors. Value is generated through advanced extraction technologies and formulation capabilities, while capture occurs via B2B distribution channels and end-use product integration. The ecosystem is shaped by agricultural inputs, technical innovation, and regulatory frameworks governing pharmaceutical and nutraceutical applications.

Raw material suppliers — supply Astragalus root and other botanical inputs for polysaccharide extraction

Technology providers — develop specialized extraction technologies to optimize yield and purity

Processors/Manufacturers — refine raw materials into standardized Astragalus Polysaccharide products

Distributors/Channel Partners — facilitate B2B distribution to pharmaceutical and nutraceutical sectors

End Users — include pharmaceutical, nutraceutical, and dietary supplement manufacturers

Regulators/Standards Bodies — oversee quality, safety, and regulatory compliance across production stages

Service Providers — offer analytical testing, quality assurance, and certification services

Control points reside with technology providers holding proprietary extraction patents and regulators enforcing compliance. Dependency risks include raw material availability and access to validated processing methods. Switching costs are elevated for manufacturers relying on exclusive technology partnerships. Ecosystem dynamics may vary by region due to differences in agricultural practices, patent enforcement, and health regulatory requirements.

Recent Industry Insights

The Astragalus Polysaccharide industry trends over the past 18 months reflect a dynamic shift driven by innovation and demand for immune-boosting solutions. Key players have prioritized strategic partnerships, such as the 2023 collaboration between BioHerbTech and China National Herbal Medicine Corp to enhance extraction efficiency and scale production. Meanwhile, product/technology launches have gained traction, including plant-based Astragalus Polysaccharide derivatives with enhanced bioavailability introduced by leading nutraceutical firms in 2024.

Regulatory changes have also influenced the market, particularly in the EU and U.S., where updated guidelines on natural health products have streamlined approvals for supplements containing Astragalus Polysaccharide. Consumer trends show increased interest in preventive healthcare, with 60% of surveyed buyers in 2024 citing immune support as a primary driver for purchasing. Additionally, funding rounds have surged, with startups like AgriBioSolutions securing $12 million in Series A financing in late 2023 to expand into Asia-Pacific markets.

Analyst Overview

The Astragalus Polysaccharide market outlook remains highly attractive due to escalating demand for natural immunomodulators and functional food additives. With a moderate competitive intensity, the market is dominated by key players leveraging R&D investments and strategic partnerships to strengthen their foothold. Long-term growth is underpinned by rising consumer preference for plant-based therapeutics and expanding applications in nutraceuticals and cosmetics. The innovation landscape is dynamic, with advancements in extraction technologies and bioavailability enhancement driving product differentiation. Currently, demand-supply balance is stable, though potential bottlenecks in raw material sourcing may emerge due to climate variability. Key risk factors include regulatory scrutiny over product standardization, price volatility of raw materials, and competition from synthetic alternatives. Stakeholders must prioritize sustainable sourcing and quality control to mitigate these risks and capitalize on the market’s growth trajectory.

12 items

1. Executive Summary

2. Astragalus Polysaccharide Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Astragalus Polysaccharide Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Astragalus Polysaccharide Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Astragalus Polysaccharide Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Astragalus Polysaccharide Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Astragalus Polysaccharide Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Astragalus Polysaccharide Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Astragalus Polysaccharide Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Astragalus Polysaccharide Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Astragalus Polysaccharide Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Astragalus Polysaccharide Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Astragalus Polysaccharide Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Astragalus Polysaccharide Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Astragalus Polysaccharide Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Astragalus Polysaccharide Market Competition by Key Manufacturers

9.1. Global Astragalus Polysaccharide Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Astragalus Polysaccharide: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Beijing Centre Biology

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Shanxi Pure Source Bio-Tech

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. HuaTai

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. HeiBei Huiyuan Pharmaceutical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Taiyuan Xingyuan Biochemical Co.,Ltd

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Shaanxi Guosheng Industries co.,ltd

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Sichuan Huayang Pharmaceutical Co.,Ltd

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Chengdu King-tiger Pharm-chem. Tech. Co.,Ltd

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. 3bio

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Xuancheng Baicao Pharmaceutical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Astragalus Polysaccharide Market

Figure 4: Global Astragalus Polysaccharide Market: Drivers

Figure 5: Global Astragalus Polysaccharide Market: Challenges

Figure 6: Global Astragalus Polysaccharide Market: Trends

Figure 7: Global Astragalus Polysaccharide Market: Opportunity

Figure 8: Global Astragalus Polysaccharide Market: Restraint

Figure 9: Global Astragalus Polysaccharide Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Astragalus Polysaccharide Market Value (USD Million) By Region

Figure 19: Global Astragalus Polysaccharide Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Astragalus Polysaccharide Market Value (USD Million) By Region

Figure 27: Global Astragalus Polysaccharide Market Share (%) By: Regions (2032)

Figure 28: Global Astragalus Polysaccharide Market Volume (K) By Region

Figure 29: Global Astragalus Polysaccharide Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Astragalus Polysaccharide Market Value (USD Million) By Region

Figure 37: Global Astragalus Polysaccharide Market Share (%) By: Regions (2032)

Figure 38: Global Astragalus Polysaccharide Market Volume (K) By Region

Figure 39: Global Astragalus Polysaccharide Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Astragalus Polysaccharide Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Astragalus Polysaccharide Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Astragalus Polysaccharide Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Astragalus Polysaccharide Market Value (USD Million) By Region

Table 14: Global Astragalus Polysaccharide Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Astragalus Polysaccharide Market Volume (K) By Region

Table 31: Global Astragalus Polysaccharide Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Astragalus Polysaccharide Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Astragalus Polysaccharide Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Astragalus Polysaccharide Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Beijing Centre Biology Basic Information And Sales Area

Table 52: Beijing Centre Biology. Products Portfolio

Table 53: Shanxi Pure Source Bio-Tech Basic Information And Sales Area

Table 54: Shanxi Pure Source Bio-Tech. Products Portfolio

Table 55: HuaTai Basic Information And Sales Area

Table 56: HuaTai. Products Portfolio

Table 57: HeiBei Huiyuan Pharmaceutical Basic Information And Sales Area

Table 58: HeiBei Huiyuan Pharmaceutical. Products Portfolio

Table 59: Taiyuan Xingyuan Biochemical Co.,Ltd Basic Information And Sales Area

Table 60: Taiyuan Xingyuan Biochemical Co.,Ltd. Products Portfolio

Table 61: Shaanxi Guosheng Industries co.,ltd Basic Information And Sales Area

Table 62: Shaanxi Guosheng Industries co.,ltd. Products Portfolio

Table 63: Sichuan Huayang Pharmaceutical Co.,Ltd Basic Information And Sales Area

Table 64: Sichuan Huayang Pharmaceutical Co.,Ltd. Products Portfolio

Table 65: Chengdu King-tiger Pharm-chem. Tech. Co.,Ltd Basic Information And Sales Area

Table 66: Chengdu King-tiger Pharm-chem. Tech. Co.,Ltd. Products Portfolio

Table 67: 3bio Basic Information And Sales Area

Table 68: 3bio. Products Portfolio

Table 69: Xuancheng Baicao Pharmaceutical Basic Information And Sales Area

Table 70: Xuancheng Baicao Pharmaceutical. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Astragalus Polysaccharide Market Value (USD Million) By Region

Table 80: Global Astragalus Polysaccharide Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Astragalus Polysaccharide Market Volume (K) By Region

Table 97: Global Astragalus Polysaccharide Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Astragalus Polysaccharide Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	775.46 million
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Beijing Centre Biology; Shanxi Pure Source Bio-Tech; HuaTai; HeiBei Huiyuan Pharmaceutical; Taiyuan Xingyuan Biochemical Co.,Ltd; Shaanxi Guosheng Industries co.,ltd; Sichuan Huayang Pharmaceutical Co.,Ltd; Chengdu King-tiger Pharm-chem. Tech. Co.,Ltd; 3bio; Xuancheng Baicao Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options